The Medical Educator Consortium

The Medical Educator Consortium MEC provides activities that stimulate productive exchanges of ideas among specialties in medicine.

04/06/2026

That’s a wrap on an incredible MaTOS GU 2026! 🥂🏙️

From the intense oncology-focused debates to the vibrant culture of historic Savannah, this year was all about the wonderful togetherness that drives oncology forward. We explored the latest in RCC research, the evolution of urothelial carcinoma care, and the groundbreaking potential of machine learning in precision medicine 🧬🩺

Thank you to our world-class faculty, our dedicated sponsors, and every attendee who made this summit a masterclass in collaboration!

Ready to do it all again? 🌵✨ Stay tuned to our social channels and meccinc.com for exciting updates and early details on MaTOS GU 2027. We can't wait to see you there!

CancerResearch MaTOS2027 FutureOfOncology

⏳ EARLY BIRD RATES ENDING SOON!Don’t miss your chance to join us at SPS Denver: Specialty Pharmaceutical Summit at a dis...
04/03/2026

⏳ EARLY BIRD RATES ENDING SOON!

Don’t miss your chance to join us at SPS Denver: Specialty Pharmaceutical Summit at a discounted rate. Early bird pricing is officially valid until April 15, 2026!

Secure your spot now for two days of high-level discussions on:
🔹 Development strategies
🔹 Regulatory pathways
🔹 Practical implementation insights

📍 The Ritz-Carlton, Denver
🗓️ May 15-16, 2026
🔗 Register today at sps-denver.com

Precision Medication Center of Colorado Jennifer Bryant Mendez Colorado Pharmacists Society

04/02/2026

From Breakthrough to Blueprint: A look back at the research that changed everything for HER2+ breast cancer. 🧬

In this snippet from MaTOS Breast Edition, Dr. Hope Rugo sits down with Dr. Slaman to discuss the evolution of breast cancer innovation since his landmark 1987 paper. We’ve come a long way from HER2+ being the most challenging subtype to one with some of the best outcomes today.

📺 Watch the full interview on our YouTube or Spotify!
www.youtube.com/watch?v=cBocvJc8RqU

The countdown is on! ⏳ We are officially ONE WEEK AWAY from the 2026 Spring to Life Conference: Multiple Myeloma Edition...
03/31/2026

The countdown is on! ⏳ We are officially ONE WEEK AWAY from the 2026 Spring to Life Conference: Multiple Myeloma Edition.

Join us in Albany for two days of high-level clinical insights, emerging research, and practical strategies to improve patient outcomes in plasma cell disorders.

Don't miss your chance to:
✨ Stay current with the latest advances in Myeloma care.
✨ Earn up to 9.25 CME/CE credits.
✨ Network with leading experts and colleagues.

📍 Where: Albany Capital Center | Albany, NY
🗓️ When: April 10-11, 2026

Space is limited and demand is high—secure your spot today!
🔗 Register Now! - web.cvent.com/event/1ce7b28b-1cc0-4ddd-9fa0-81f62727ee4a/summary

Hematology NYOH AlbanyNY

Are we optimizing the right strategy in Advanced NSCLC? 🩺🤔The landscape of first-line immunotherapy is evolving rapidly....
03/29/2026

Are we optimizing the right strategy in Advanced NSCLC? 🩺🤔

The landscape of first-line immunotherapy is evolving rapidly. Today at the Multidisciplinary Thoracic Tumor Board Conference, we tackled the critical nuances of IO strategy in advanced-stage disease.

Key Insights from the session:
- PD-L1 remains a critical biomarker guiding therapy
- Chemo-immunotherapy demonstrates durable survival benefit
- IO-IO combinations may benefit high-risk patients

A huge thank you to our moderators for leading this high-level discussion:
👤 Anne Chiang, MD, PhD
👤 Robert Millett IV, MD

💬 Discussion Points:
- Optimal sequencing and duration of therapy
- Personalization using biomarkers and co-mutations
- Management of resistance

CancerCare MTTB2026 PrecisionMedicine

MRD in Early-Stage NSCLC: Breakthrough or Not Yet? 🧬🔬The conversation around Minimal Residual Disease (MRD) is heating u...
03/28/2026

MRD in Early-Stage NSCLC: Breakthrough or Not Yet? 🧬🔬

The conversation around Minimal Residual Disease (MRD) is heating up here at MTTB 2026. As we look at the evolution of ctDNA—from its first detection in 1948 to the clinical validations of today—the big question remains: Is it ready for prime time?

Key Insights from the session:
- Outcome Correlation: MRD positivity is consistently linked to worse clinical outcomes.
- Survival Indicators: Conversely, ctDNA clearance is showing a strong link to improved survival rates.
- The "Actionability" Gap: While the data is powerful, MRD status is not yet considered actionable for making definitive treatment decisions in standard practice.

We are standing on the edge of a major shift in how we monitor lung cancer, but we’re not quite there yet.

💬 Engagement Prompt: If a patient is MRD positive after surgery, would you feel comfortable changing their treatment plan based on that data today? Let’s hear your clinical perspective below.

Today at the MTTB 2026 Conference, we’re diving into the data that is shifting the treatment paradigm for Non-Small Cell...
03/28/2026

Today at the MTTB 2026 Conference, we’re diving into the data that is shifting the treatment paradigm for Non-Small Cell Lung Cancer. The integration of perioperative immunotherapy with chemotherapy is showing significant promise in improving patient outcomes.

Key Takeaways from the Discussion:
- Outcome Improvements: Perioperative IO + chemotherapy is consistently raising the bar for survival.
- Stage III Benefit: The most significant clinical benefit is currently being observed in Stage III disease.
- pCR as a Marker: Pathologic Complete Response (pCR) is emerging as an incredibly strong predictor of overall survival.

A special thank you to our expert moderators for leading this session:
👤 David R. Gandara, MD
👤 Gavitt Woodard, MD
👤 Jordan Dozier, MD

💬 Engagement Prompt: How are you currently approaching sequencing in resectable NSCLC? Are you moving toward a perioperative approach for your patients? Let’s discuss in the comments.

MedicalEducation MTTB2026 ThoracicOncology

03/28/2026

We are live at The Southern Hotel in Covington for the 2026 Multidisciplinary Thoracic Tumor Board Conference. The room is filled with the brightest minds in oncology, all focused on one goal: advancing the future of thoracic cancer care through real-world, case-based learning.

Stay tuned for more updates as we dive into a full day of expert-led sessions and interactive tumor boards!

📍 Covington, Louisiana 🗓️ March 28, 2026

TumorBoard CancerCare LiveEvent

📍 We are just two weeks away from the 2026 Spring to Life Conference: Multiple Myeloma Edition.This two-day event brings...
03/27/2026

📍 We are just two weeks away from the 2026 Spring to Life Conference: Multiple Myeloma Edition.

This two-day event brings together leading experts to dive into the ever-changing landscape of plasma cell disorders. From evolving treatment strategies to real-world clinical insights, this is an essential meeting for healthcare professionals dedicated to advancing patient care.

🗓 Dates: April 10-11, 2026
🏢 Location: Albany Capital Center | Albany, NY
🎓 Co-Directors: Pooja Chaukiyal, MD & Mihir Raval, MD, MPH

Space is limited!
Secure your spot today! - web.cvent.com/event/1ce7b28b-1cc0-4ddd-9fa0-81f62727ee4a/summary 🔗

AlbanyNY Hematology

LAST CHANCE TO REGISTER! 🚨The 2026 Multidisciplinary Thoracic Tumor Board Conference (MTTB) is happening THIS SATURDAY, ...
03/26/2026

LAST CHANCE TO REGISTER! 🚨

The 2026 Multidisciplinary Thoracic Tumor Board Conference (MTTB) is happening THIS SATURDAY, March 28th, at The Southern Hotel in Covington, LA.

Don’t miss this opportunity to engage in high-level, case-based learning with a multidisciplinary panel of experts. This is your final opportunity to secure a spot for a day dedicated to advancing clinical decision-making in thoracic oncology.

✨ Featuring Experts From:
- Yale Medicine
- City of Hope
- Ochsner MD Anderson Cancer Center
- UC Davis Comprehensive Cancer Center..and more!

🔗 Register Now! - web.cvent.com/event/67b56a89-74b2-472b-bc55-4ca6d401afb6/summary

MedicalEducation LungCancerResearch MTTB2026

03/21/2026

The GU oncology field is evolving faster than ever. 🧬✨

We sat down with the incredible Dr. Maha Hussain (Northwestern University) and Dr. Petros Grivas at MaTOS GU 2026 to discuss why group debate and expert opinions are more critical now than ever before. As Dr. Hussain says, "We learn from each other." 🤝💡

Full interview dropping soon on Spotify and YouTube! Stay tuned to catch this masterclass in clinical collaboration. 🎧📺


Teri Valls Chandler Park M.D. Edgardo Santos Castillero Luis E. Raez

03/21/2026

AI and Oncology: A match made in medicine. 🧬🤖

We’re taking a deep dive into the future at MaTOS GU 2026! This session explores how machine learning and deep learning are revolutionizing clinical decision-making in prostate cancer.

From increasing diagnostic accuracy to optimizing treatment strategies through AI-driven pathology tools, we are witnessing the dawn of precision oncology. Savannah is officially the hub for the next generation of cancer care! 🔬🏙️

Speaker:
David M. Albala, MD
Chief of Urology – Crouse Hospital, Syracuse, NY
Edgardo Santos Castillero Luis E. Raez Teri Valls Chandler Park M.D.

Address

6619 S. Dixie Highway #341
Miami, FL
33143

Website

Alerts

Be the first to know and let us send you an email when The Medical Educator Consortium posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category